ADA2 and infection: Finally, we examined the effect of GSK343 treatment on de novo infection of 293T cells with rKSHV.219, a recombinant virus that expresses the green fluorescent protein (GFP) from the cellular EF-1α promoter and the red fluorescent protein (RFP) during lytic replication from the viral early PAN promoter [25].